ArticleFrontiers in public health2026
Factors associated with COVID-19 booster dose uptake in the Jazan region, Saudi Arabia: insights for policy improvement during pandemics.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to assess factors associated with COVID-19 booster dose uptake in the Jazan region, Saudi Arabia. Methods: A sample of 467 individuals participated in a cross-sectional online questionnaire between February and March 2022. Data were investigated using descriptive characteristics, Pearson's chi-square, and logistic regression tests. Results: Nearly 69.6% of respondents believed the booster dose to be necessary, while 16.3% disagreed, and 14.1% were unsure. Almost two-thirds (61.7%) of the respondents had received the booster dose, while 7.9% had booked a vaccination appointment; the remaining 30.4% had neither received nor scheduled any appointments. Furthermore, 57% of non-vaccinated respondents (n=102) planned to receive the booster dose, 19.0% did not plan to receive the vaccine (n=34), and the remaining 24.0% were hesitant (n=43). Receipt of the booster dose of the vaccine was associated with the respondents' attitude, gender, and having not been previously diagnosed with COVID-19 ( Conclusions: The COVID-19 virus and similar viruses continue to be a possible health risk due to the potential emergence of new, severe variants in the future. Understanding vaccine hesitancy can help manage the acceptance of booster doses and guide the development of targeted awareness campaigns for future disease outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.